Ancillary Advantage Revenue and Competitors
Estimated Revenue & Valuation
- Ancillary Advantage's estimated annual revenue is currently $7.3M per year.
- Ancillary Advantage's estimated revenue per employee is $216,000
Employee Data
- Ancillary Advantage has 34 Employees.
- Ancillary Advantage grew their employee count by -6% last year.
Ancillary Advantage's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | Reimbursement Manager | Reveal Email/Phone |
Ancillary Advantage Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.1M | 27 | -4% | N/A | N/A |
#2 | $6.5M | 30 | -12% | N/A | N/A |
#3 | $271.4M | 869 | N/A | N/A | N/A |
#4 | $26.2M | 97 | -5% | N/A | N/A |
#5 | $7.3M | 34 | 3% | N/A | N/A |
#6 | $89.1M | 300 | 49% | N/A | N/A |
#7 | $7.1M | 33 | 0% | N/A | N/A |
#8 | $170.4M | 505 | -3% | N/A | N/A |
#9 | $9.7M | 45 | -4% | N/A | N/A |
#10 | $42.5M | 143 | 5% | N/A | N/A |
What Is Ancillary Advantage?
Ancillary Advantage provides solutions for dispensing orthopaedic products (DME) & on site prescription medications. With over a decade of experience our programs have become an integral part of practices looking to increase their ancillary revenues. Since 1999 the professionals at Ancillary Advantage have effectively managed and created opportunities for over 500 physicians nationwide. We understand that patient outcomes are the key to a successful practice’s income. Let Ancillary Advantage provide you with our seamless solutions and realize the unparalleled ancillary opportunities that await your practice!
keywords:N/AN/A
Total Funding
34
Number of Employees
$7.3M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.3M | 34 | 3% | N/A |
#2 | $3.9M | 34 | 17% | N/A |
#3 | $3.9M | 34 | 10% | N/A |
#4 | $3.9M | 34 | 0% | N/A |
#5 | $7.5M | 34 | -11% | N/A |